New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 4, 2012
12:24 EDTINFA, VRNG, BKE, APP, COST, NUVA, FB, ROST, GPS, CX, GOOG, KSS, TGTOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday after initial jobless claims stayed below 370K for another week. The market opened slightly higher and drifted in positive territory during the early hours of trading. The market reached its highs near the time the headline number for factory orders showed a decline of more than 5% for the month. When transportation items were removed from the data, orders managed to show a slight increase. The market briefly reached new five year highs but then backed off and the averages have been drifting near noon... ECONOMIC EVENTS: In the U.S., jobless claims rose 4,000 to 367,000 in the week ended September 29, versus expectations for 370,000 claims. The Challenger job cuts report showed job cuts were roughly 70% lower than in the same period a year ago. Factory orders were down 5.2% in August, versus expectations for a decrease of 5.9%. In Europe, the Bank of England left its interest rates and stimulus unchanged and the European Central Bank left its benchmark rate unchanged as well. In his post announcement press conference, ECB president Mario Draghi refused to comment directly on the chances Spain was on the verge of a bailout, but said the ECB's Outright Monetary Transactions bond buying program could act quickly if a country asks for help... COMPANY NEWS: Numerous retailers reported September same-store sales figures, with a number of discount and specialty-apparel chains topping analysts’ estimates and some department stores trailing projections. Stocks advancing after the reports included Costco (COST), Target (TGT), Gap (GPS) and American Apparel (APP), while decliners included Kohl's (KSS), Ross Stores (ROST) and The Buckle (BKE)... Google (GOOG) said it is expanding its plan to cut jobs from its Motorola Mobility unit and will take $340M in related charges in Q3... Facebook (FB) now has 1B active users, CEO Mark Zuckerberg announced in a statement on its Web site... MAJOR MOVERS: Among the notable gainers was Vringo (VRNG), which extended yesterday's gains to rise another 20% the day after a federal judge ordered the company and Google to engage in patent litigation settlement talks. Also higher were shares of CEMEX (CX), which rose nearly 5% after it said that it expects its Q3 net sales to grow about 3% when adjusted for currency fluctuations. Among the noteworthy losers was NuVasive (NUVA), which fell over 32% following at least seven downgrades of its stock after the company lowered its outlook for Q3. Also lower was Informatica (INFA), down 26% following downgrades at Oppenheimer and Evercore after the company's Q3 outlook missed expectations... INDICES: Near noon, the Dow was up 84.98, or 0.63%, to 13,579.59; the Nasdaq was up 7.33, or 0.23%, to 3,142.56; and the S&P 500 was up 8.98, or 0.62%, to 1,459.97.
News For COST;TGT;GPS;APP;KSS;ROST;BKE;GOOG;FB;VRNG;CX;NUVA;INFA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
January 13, 2015
08:12 EDTNUVANuVasive downgraded to Neutral from Buy at Summer Street
Subscribe for More Information
07:28 EDTNUVANuVasive price target raised to $55 from $50 at RW Baird
Subscribe for More Information
05:42 EDTCOSTCostco downgraded to Neutral from Buy at Goldman
Subscribe for More Information
January 12, 2015
16:06 EDTNUVANuVasive COO Valentine to step down, Miles named as successor
NuVasive announced changes to its leadership team designed to enhance the company's organizational alignment. Pat Miles, NuVasive's current President of Global Products and Services, will assume an expanded role as President and Chief Operating Officer. The company also announced that NuVasive's COO Keith Valentine will step down from that role and be leaving the company effective April 30. Valentine is committed to working with the company to ensure a seamless transition of responsibilities over the coming months, the company said.
16:04 EDTNUVANuVasive sees Q4 revenue $203M, consensus $199.95M
Subscribe for More Information
16:04 EDTNUVANuVasive sees FY15 revenue $810M, consensus $811.7M
Subscribe for More Information
16:02 EDTNUVANuVasive sees FY14 revenue $761M, consensus $758.16M
NuVasive provided a business and financial performance update, including the announcement of select preliminary unaudited financial results for FY14. The company sees preliminary FY14 revenue of approximately $761M, which reflects 11% growth over the prior year or 12% on a constant currency basis. Preliminary FY14 non-GAAP operating margin is anticipated to exceed guidance of 16.5%.
13:14 EDTGOOGAnalysts take opposite sides in regards to Google shares
Subscribe for More Information
11:48 EDTFBFacebook February volatility elevated at 39
Facebook January call option implied volatility is at 32, January weekly is at 29, February is at 39, March Is at 33; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement.
11:19 EDTGOOGGoogle set to provide real-time translation via Translate app, NY Times reports
Subscribe for More Information
10:24 EDTFBFacebook, Xiaomi held talks over Facebook investment, Reuters says
Subscribe for More Information
10:12 EDTFBFacebook discussed potential investment in Xiaomi, Reuters reports
Subscribe for More Information
10:00 EDTGOOGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTGOOGGoogle no longer fixing older Android security flaws, WSJ reports
Subscribe for More Information
09:22 EDTGOOG23andMe announces collaboration with Pfizer
Google (GOOG)-backed 23andMe announced an agreement with Pfizer (PFE) that will provide Pfizer with access to 23andMe’s research platform, including services and Research Portal analysis of 23andMe’s genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research. 23andMe’s Research Portal enables qualified and approved scientists outside of 23andMe the opportunity to leverage the company’s unique research model while still protecting the privacy and security of 23andMe’s customers. As a part of the agreement, the companies will collaborate on certain genome-wide association studies, surveys, and clinical trial recruitment. One of these collaborations will be a longitudinal study to better understand the genetics of lupus. This study will entail enrollment and genotyping of 5,000 people into a new lupus research community, and include the integration of medical records, targeted bio-sampling along with genetic information for all participants. This announcement follows a collaboration between 23andMe and Pfizer to enroll 10,000 people with Inflammatory Bowel Disease in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Nearly 4,000 patients have been enrolled in the community since August 2014.
08:21 EDTGOOGApple poised to gain market share, says JMP Securities
Subscribe for More Information
08:02 EDTGOOGGoogle shares undervalued, says Bernstein
Subscribe for More Information
07:38 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
06:46 EDTGOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
06:35 EDTKSSObama to press for law requiring disclosure of hacking, NY Times says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use